BoxOne Ventures

Stately Bio operates in stealth mode and focuses on advancing the understanding of cellular dynamics through its innovative technology. The company has developed patented machine learning methods that allow for the measurement of cell identity, behavior, and maturation through live-cell, label-free imaging. This approach enables researchers to gain insights into cells while maintaining their viability, providing a valuable tool for various applications in biological research and medicine.

Dispersa specializes in the development of environmentally friendly biosurfactants, which are derived from food waste instead of traditional food-grade sources. By utilizing microbes, the company transforms food waste into sustainable surfactants that effectively disperse oil particles. These biosurfactants form micelles, structures that encapsulate hydrocarbons, facilitating their breakdown and removal. Dispersa's innovative approach aims to enhance the sustainability and affordability of the biosurfactant market, offering a viable alternative to synthetic and petroleum-based surfactants. This positions Dispersa as a leader in providing eco-friendly solutions for various industries, promoting a circular economy and reducing reliance on non-renewable resources.

CytoTronics specializes in the design and development of advanced cell culture plates that incorporate high-density electronic systems. Its semiconductor-based technology facilitates the visualization of live cell functions at scale, providing researchers with real-time data on cellular behavior. This capability enhances the study of complex biological processes, which may lead to significant advancements in drug discovery and personalized medicine. By enabling a deeper understanding of cell biology, CytoTronics aims to support innovative research and foster breakthroughs in various scientific fields.

Talus Bio is a biotech startup focused on drug discovery, particularly in the development of therapies targeting gene regulators for cancer treatment. The company utilizes a data-enabled platform that combines functional proteomics, automated biology, and machine learning to address the challenges associated with cancer transcription factors. Its proprietary MARMOT platform employs advanced techniques such as AI, quantitative proteomics, synthetic chemistry, and computational biology to design and analyze small-molecule drugs and proteins. This innovative approach aims to enhance drug development processes in the oncology sector, facilitating advancements in gene regulation and contributing to more effective cancer therapies.

Opalia is a manufacturer of milk and milk ingredients derived from mammary cells, aiming to provide an alternative to traditional cow milk. The company utilizes advanced technology that allows it to produce real milk without the use of cows, ensuring that its products maintain comparable concentrations of nutrients and flavor to conventional dairy. Opalia's offerings are designed to meet the performance and taste expectations of consumers while promoting a more sustainable and ethical approach to dairy production. Through its innovative methods, Opalia is positioned to deliver high-quality milk and milk ingredients that cater to the growing demand for alternatives to traditional dairy products.

Pathway is a health technology company focused on enhancing access to essential medical information for clinicians and patients during the care journey. The company develops a point-of-care reference tool that provides rapid access to evidence-based clinical guidelines. By organizing and condensing medical literature, Pathway aims to make critical information more accessible and easier to understand for healthcare professionals. This approach enables clinicians to work more efficiently, ultimately improving patient outcomes. Leveraging artificial intelligence and big data, Pathway creates a medical knowledge graph and software solutions that integrate evidence-based medicine into clinical practice.

BioLoomics, Inc. is a biotechnology company based in Boulder, Colorado, founded in 2019. It specializes in drug screening services that analyze drug action and toxicity through the use of biosensors and advanced imaging technology. BioLoomics develops tools aimed at enhancing drug discovery by employing directed evolution to create antibodies with programmable spatial fate in target cells. The company's technology facilitates high-throughput multiplexed profiling of biochemical events in live mammalian cells, allowing for the screening of chemical libraries and bioactive nanoparticles. This innovative approach enables clients to observe unique cellular responses and sustainably induce hormone secretion, ultimately improving the success rates and reducing costs associated with drug development.

Vivid Machines is a startup focused on enhancing agricultural production for fruit and vegetable farmers through innovative technology. The company develops advanced vision sensors and machine learning systems that deliver plant-specific insights, allowing farmers to capture critical information about their crops that was previously unnoticed. This technology enables farmers to digitize the physical and chemical attributes of their fields, facilitating more informed decision-making and increasing the proportion of produce that reaches grocery stores. Vivid Machines' system operates in real-time, quantifying fruit and size distribution, identifying pests and diseases, and evaluating overall plant health. By integrating seamlessly into existing workflows, the company provides valuable data to growers, pack houses, and fruit marketers, ultimately optimizing the fruit supply chain.

Nimble Science Ltd. is a digital health company focused on transforming gastrointestinal health through its innovative SIMBA capsule technology. This platform enables the passive sampling of small bowel luminal fluid, allowing for the collection of precision datasets related to the gastrointestinal tract. By utilizing multi-omic mapping, Nimble Science provides healthcare providers with direct insights into specific regions of the GI system, facilitating improved diagnosis and treatment strategies. The company's approach represents a significant advancement in understanding and managing gastrointestinal health.

Magnestar is focused on developing advanced software and hardware solutions to predict and manage communication outages between Earth and space. The company provides a clearing house exchange platform that enables users to monitor signal communications in outer space, conduct interference simulations, and ensure compliance with spectrum regulations in real-time. By equipping assets with its technology, Magnestar enhances the longevity and quality of service of both satellite and Earth systems. This technology is designed for operators, regulators, and military personnel, allowing for effective analysis and coordination of radio frequency interactions. Ultimately, Magnestar aims to improve safety in space and facilitate reliable space services that support human exploration and operations.

Odd Burger is a plant-based food technology company focused on manufacturing and distributing plant-based protein and dairy alternatives. Founded in 2014, originally under the name Globally Local, the company began as a delivery service for food boxes and a market for plant-based produce. Odd Burger aims to provide affordable access to plant-based foods, promoting better health, environmental protection, and animal welfare. The company utilizes locally sourced and sustainable ingredients in its products, which are distributed through a proprietary food service line to both company-owned and franchised fast-food restaurant locations. These restaurants operate as smart kitchens, employing advanced cooking technology and automation to offer customers a healthier and more sustainable fast-food experience. Odd Burger also maintains a manufacturing facility and has several restaurant locations in Canada.

Seqera develops workflow orchestration software aimed at simplifying complex data analysis for life sciences research. The company's platform consolidates fragmented data and diverse computing resources, enabling scientists to create and deploy scalable data analysis pipelines in multi-cloud environments with ease. By empowering researchers with modern software tools, Seqera enhances productivity and accelerates scientific discovery across fields such as genomics and global health. Trusted by over 150 leading life science organizations, Seqera's solutions facilitate faster and more confident scientific inquiry, supporting innovation and collaboration in an increasingly data-driven world.

Wayfinder Biosciences is a biotechnology company based in Seattle, WA, focused on developing orally available small molecule drugs that target RNA to address key disease areas such as oncology and neurodegenerative disorders. Established in 2021, the company employs a proprietary platform that integrates advanced screening technologies and computational methods to efficiently discover potent and selective RNA-targeting molecules. By leveraging high-throughput screening combined with machine learning and unique datasets, Wayfinder aims to enable the development of drugs for traditionally inaccessible targets, thus addressing significant unmet medical needs in genetic diseases, cancer, and other conditions.

Covey is an analyst-led community focused on identifying and rewarding emerging talent in money management. The company has developed a financial platform that facilitates the creation and sharing of portfolios among users. This platform allows analysts to share portfolio analytics across various communities while aggregating trade-level data on equities. By providing a sophisticated mock portfolio trading suite, Covey assists hedge funds and investment institutions in refining their trading strategies, ultimately enhancing their investment decision-making processes.

Spiderwort is a company focused on developing innovative biomaterials for regenerative medicine, aiming to repair and regenerate human tissues. Founded in 2015 and based in Ottawa, Ontario, the company utilizes plant-derived cellulose to create various scaffold architectures, including powders, gels, membranes, and pastes. Currently in the pre-clinical stage, Spiderwort's novel biomaterials have shown promising results in terms of biocompatibility and their ability to induce angiogenesis, the generation of new blood vessels within the scaffolds. This approach seeks to advance applications in the healthcare industry, particularly for spinal cord injury repair and soft tissue regeneration, by utilizing plant-based materials rather than traditional synthetic substances.

Unravel Biosciences is a therapeutics company that originated from the Wyss Institute at Harvard University, focusing on developing new treatments for complex disorders. The company employs a unique approach by utilizing existing drugs to identify and clinically validate new therapeutic targets. Its AI-powered discovery engine integrates a comprehensive model of human health with rapid in vivo screening, allowing for the identification of drug targets at a significantly faster and more cost-effective rate than traditional methods. Unravel's platform has demonstrated its efficacy through discoveries that are currently being advanced into four clinical trials. Additionally, the company has built a robust portfolio of intellectual property and clinical samples, supported by partnerships established through its rareSHIFT™ services arm, positioning it for a rapid expansion of its therapeutics pipeline while maintaining profitability.

Isabl is a startup focused on developing advanced diagnostic assays for cancer through whole-genome and RNA sequencing. Founded in 2020 after incubating its technology at Memorial Sloan Kettering Cancer Center from 2015 to 2019, Isabl participated in the Winter 2020 batch of Y Combinator and has raised $3 million in seed funding from investors including Two Sigma Ventures and BoxOne Ventures. In 2021, the company received the FDA Breakthrough Device designation, highlighting the innovative nature of its cancer diagnostic tests. Additionally, Isabl was awarded a $2 million direct-to-phase-2 SBIR grant from the National Cancer Institute to further the development of its specialized test, Isabl GxT, aimed at pediatric and rare solid tumors. The leadership team, comprising Dr. Elli Papaemmanuil, Dr. Andrew Kung, and Juan Medina, brings extensive expertise in precision medicine, computational biology, and software engineering, with a proven history in biomarker discovery and clinical decision support. Isabl's platform enhances the ability of oncology centers to analyze genomic data effectively and supports the creation of data-driven automation in cancer diagnosis.

SX Network operates a blockchain-based platform focused on sports betting, providing users with enhanced odds, transparency, and security for their funds. The platform integrates smart contracts with an on-chain community treasury, allowing for a decentralized prediction market that is governed by a prediction market-based system. This structure enables users to engage in sports betting while benefiting from the advantages of blockchain technology, such as improved trust and accountability in transactions. By combining these elements, SX Network aims to revolutionize the sports betting experience for its users.

DrugBank is a developer of a comprehensive drug knowledge platform aimed at enhancing healthcare delivery and accelerating drug research. Its extensive database offers detailed information about drugs, their mechanisms of action, and interactions, which aids healthcare professionals in making informed decisions. The platform includes tools for drug search, interaction checking, allergy information, and drug labeling, facilitating precision medicine and clinical software applications. By integrating its knowledge base into various software solutions, DrugBank enables companies to leverage advanced insights and data science for drug discovery, helping to identify novel drug candidates and opportunities for drug repurposing. Additionally, DrugBank Online serves as a publicly available resource, offering limited datasets for academic and non-commercial researchers. With over 13,000 citations in academic publications, DrugBank is widely utilized by researchers and health professionals worldwide.

Shakepay Inc. is a Montreal-based technology company that offers financial applications focused on cryptocurrency. Founded in 2015, it provides a platform for Canadians to buy and sell Bitcoin, as well as a peer-to-peer mobile wallet that facilitates secure transactions between users. The company also offers a VISA debit card that allows cardholders to load and spend Bitcoin, enabling point of sale transactions, ATM withdrawals, and online purchases. Shakepay aims to simplify cryptocurrency trading and enhance users' financial capabilities.

TriplePlay is a Toronto-based virtual social network founded in 2020 that enables users to connect with others through interactive games and video-based communication. The platform offers features that allow users to engage in one-on-one or group conversations, participate in workshops, panel discussions, and live demonstrations. Additionally, it includes chat functionalities and customization options, enhancing the overall experience of social video communication. Through its engaging environment, TriplePlay aims to facilitate meaningful connections between users while making interactions more enjoyable and natural.

Coinmiles operates a Bitcoin-based reward platform that allows users to earn Bitcoin rewards while shopping online or in physical stores at over 1,000 brands and when traveling at more than 900,000 hotels globally. The application offers cashback in the form of Bitcoin, which users can convert to cash as needed. In addition to providing rewards to consumers, Coinmiles is developing a comprehensive ecosystem that assists brands in managing and promoting their offerings, thereby enhancing user acquisition and engagement. This innovative platform aims to create a seamless experience for both shoppers and brands in the cryptocurrency landscape.

Pathway is a health technology company focused on enhancing access to essential medical information for clinicians and patients during the care journey. The company develops a point-of-care reference tool that provides rapid access to evidence-based clinical guidelines. By organizing and condensing medical literature, Pathway aims to make critical information more accessible and easier to understand for healthcare professionals. This approach enables clinicians to work more efficiently, ultimately improving patient outcomes. Leveraging artificial intelligence and big data, Pathway creates a medical knowledge graph and software solutions that integrate evidence-based medicine into clinical practice.

Seqera develops workflow orchestration software aimed at simplifying complex data analysis for life sciences research. The company's platform consolidates fragmented data and diverse computing resources, enabling scientists to create and deploy scalable data analysis pipelines in multi-cloud environments with ease. By empowering researchers with modern software tools, Seqera enhances productivity and accelerates scientific discovery across fields such as genomics and global health. Trusted by over 150 leading life science organizations, Seqera's solutions facilitate faster and more confident scientific inquiry, supporting innovation and collaboration in an increasingly data-driven world.

Colabra specializes in enhancing the efficiency of scientific teams through its development of data integration and collaboration tools. The company provides a platform that facilitates real-time collaboration, allows for the integration of diverse data sources, and supports agile project management. This enables scientific researchers to effectively track their workflows, share data, and communicate outcomes. By streamlining these processes, Colabra aims to eliminate inefficiencies and boost research productivity, ultimately fostering a more innovative approach to scientific research and development.

Vivid Machines is a startup focused on enhancing agricultural production for fruit and vegetable farmers through innovative technology. The company develops advanced vision sensors and machine learning systems that deliver plant-specific insights, allowing farmers to capture critical information about their crops that was previously unnoticed. This technology enables farmers to digitize the physical and chemical attributes of their fields, facilitating more informed decision-making and increasing the proportion of produce that reaches grocery stores. Vivid Machines' system operates in real-time, quantifying fruit and size distribution, identifying pests and diseases, and evaluating overall plant health. By integrating seamlessly into existing workflows, the company provides valuable data to growers, pack houses, and fruit marketers, ultimately optimizing the fruit supply chain.

Revelio Labs is a developer of a labor market analytics platform that provides comprehensive insights into global workforces. By leveraging advanced AI technologies, the company processes vast amounts of online profiles, resumes, and job postings to create a standardized database of public employment records. This platform offers valuable workforce analytics, allowing corporate strategists, HR professionals, venture capitalists, and investors to understand company and market dynamics, identify skill gaps, and make informed, data-driven decisions. Revelio Labs enables its clients to uncover trends in human capital, facilitating strategic workforce planning and optimization.

Axonis Therapeutics is a biotechnology company focused on developing therapies for neurological disorders by targeting KCC2, a key mediator of inhibition in the brain. The company utilizes a proprietary discovery engine centered on the neuron-specific K-Cl cotransporter (KCC2) to address various conditions, including epilepsy and pain, as well as other central nervous system pathologies. By harnessing breakthrough research from institutions such as Boston Children’s Hospital, Harvard, and Laval University, Axonis aims to enhance the lives of individuals affected by these disorders through improved modulation of neuronal inhibition.

FabricNano is a biomanufacturing company based in London, United Kingdom, founded in 2018. The company specializes in developing biocatalysts and artificial cells to enhance chemical reaction speed, purity, and adaptability. By utilizing nanotechnology and biotechnology, FabricNano creates innovative designs and construction schematics for artificial cells that enable the production of small quantities of new target molecules at low unit costs. This approach helps businesses overcome production capacity bottlenecks and reduces costs associated with traditional manufacturing workflows, positioning FabricNano as a key player in the future of biochemistry.

Giving superpowers to medical professionals by transforming messy medical data into useful insights.

Tornado operates a social investment discussion platform aimed at enhancing the skills and profitability of investors. The platform facilitates discussions among users and experts, allowing participants to share and learn investment ideas. By providing tools for portfolio allocation, Tornado enables users to make informed investment decisions tailored to their specific objectives. This approach transforms the investing experience into a more engaging and sophisticated process compared to traditional online brokerages. Tornado's focus on community-driven investment strategies aims to empower investors of all skill levels to improve their profitability and portfolio intelligence.

Kenota Health specializes in the development of advanced diagnostic tools for allergy testing in humans. The company's innovative point-of-care system allows for the collection of small blood samples, which are analyzed using streamlined equipment to quickly determine allergen sensitization. This process delivers immediate test results, enabling physicians to obtain quality diagnostic information efficiently. By offering a safe, simple, and cost-effective alternative to traditional allergy testing methods, Kenota Health aims to enhance patient outcomes and streamline the diagnostic process in clinical settings.

Slingshot is a decentralized finance (DeFi) trading platform that enables users to access and interact with digital assets securely and independently. Founded in 2018 and based in San Francisco, California, the company aggregates prices for over 50,000 cryptocurrencies across various decentralized exchanges, allowing users to buy, sell, swap, and bridge tokens at competitive rates. Slingshot offers a user-friendly experience across Web, Android, and iOS platforms, combining the performance of centralized trading with the transparency and security of decentralized finance. Its features include multiple wallet options, live price tracking, portfolio management, and customer support, making it a comprehensive tool for retail users in the cryptocurrency market. The company changed its name from DEXAG, Inc. to Slingshot in November 2020, reflecting its commitment to enhancing user experience in the evolving digital asset landscape.

PowerTrade is a mobile platform designed for trading crypto options and derivatives, including options, futures, and perpetuals. It offers a user-friendly and efficient trading experience, catering to the needs of professional traders. By providing better prices and lower margin requirements, PowerTrade aims to help traders maximize their return on investment. The platform includes features such as a request for quote (RFQ) tool, which allows traders to manage risk effectively and obtain competitive prices for large and complex trades. Overall, PowerTrade focuses on simplifying the trading process while enhancing profitability and risk management for its users.

Injective Labs is a research and software development company that focuses on creating innovative decentralized finance solutions. It is a core contributor to Injective, a blockchain platform specifically designed for the finance sector. Injective operates as an open and interoperable network, enabling decentralized application developers to build on a foundation that is compatible with both Cosmos IBC and Ethereum. The platform offers unique benefits such as zero gas fees, secure transactions, and rapid data transmission, promoting dynamic scalability for its applications. By leveraging cryptographic research, Injective’s decentralized derivatives exchange protocol addresses significant security vulnerabilities and scaling challenges in decentralized exchanges. The overarching mission of Injective Labs is to foster a free and inclusive financial system through the principles of decentralization.

DrugBank is a developer of a comprehensive drug knowledge platform aimed at enhancing healthcare delivery and accelerating drug research. Its extensive database offers detailed information about drugs, their mechanisms of action, and interactions, which aids healthcare professionals in making informed decisions. The platform includes tools for drug search, interaction checking, allergy information, and drug labeling, facilitating precision medicine and clinical software applications. By integrating its knowledge base into various software solutions, DrugBank enables companies to leverage advanced insights and data science for drug discovery, helping to identify novel drug candidates and opportunities for drug repurposing. Additionally, DrugBank Online serves as a publicly available resource, offering limited datasets for academic and non-commercial researchers. With over 13,000 citations in academic publications, DrugBank is widely utilized by researchers and health professionals worldwide.

Sollum Technologies, based in Montréal, Canada, specializes in advanced LED lighting solutions for greenhouse producers that mimic the full spectrum of natural sunlight. The company focuses on designing, developing, and manufacturing lighting systems that adapt to the specific growth cycles of various plants, regardless of their native climates. By collaborating closely with clients, Sollum creates customized lighting recipes that enhance energy efficiency, boost productivity, and improve the quality of produce. Their innovative approach not only maximizes plant yield but also emphasizes environmental sustainability, making Sollum's offerings valuable for greenhouse and breeding farm operations seeking to optimize their growing conditions.

Floating Point Group (FPG) is a prime brokerage specializing in cryptocurrency trading, designed to facilitate access to liquidity across diverse markets for advanced trading strategies. The company operates the largest global digital asset agency trading desk, collaborating with funds and blockchain foundations to ensure efficient trade execution. FPG provides a secure custodial solution that integrates trading, settlement, and yield functionalities, along with insurance for cryptocurrencies. Its trading infrastructure is engineered specifically for the cryptocurrency ecosystem, utilizing high-quality data to develop and optimize market-efficient execution algorithms. By streamlining the trading process, Floating Point Group enables traders to enhance their performance across multiple exchanges based on time, price, and order volume.

TATUM bioscience is a synthetic biology startup focused on developing advanced biologics that combine multiple therapeutic activities into a single agent. This innovative approach aims to deliver the benefits of combination therapy while enhancing safety and efficiency in treatment. The company specializes in creating synthetic live biotherapeutic drugs designed to address diseases that conventional pharmaceuticals have struggled to treat. By utilizing probiotics equipped with unique modules, TATUM bioscience's products offer novel therapeutic activities that target various diseases and combat bacterial resistance to antibiotics, providing healthcare professionals with effective solutions for challenging medical conditions.

Botpress, Inc. is a company that specializes in designing and developing an open-source chatbot development platform. Founded in 2016 and based in Newark, Delaware, Botpress provides software that enables the creation of various types of chatbots, including scripted, artificial intelligence, and application-based options. The platform is widely used by developers, organizations, and individuals, facilitating the building, deployment, and management of chatbots. Key features include a conversational flow management system and natural language understanding, allowing businesses to create customizable conversational experiences. Additionally, the platform is designed to be manageable by non-developers after deployment, making it accessible for a broader audience to enhance their conversational strategies.

Tornado operates a social investment discussion platform aimed at enhancing the skills and profitability of investors. The platform facilitates discussions among users and experts, allowing participants to share and learn investment ideas. By providing tools for portfolio allocation, Tornado enables users to make informed investment decisions tailored to their specific objectives. This approach transforms the investing experience into a more engaging and sophisticated process compared to traditional online brokerages. Tornado's focus on community-driven investment strategies aims to empower investors of all skill levels to improve their profitability and portfolio intelligence.

ORA is a Montreal-based startup working with advanced nano-materials to produce unparalleled audio experiences. Their team of sound engineers, chemists and material scientists work with the exciting properties of *Graphene* (the strongest and lightest material known to man) to deliver smaller/lighter, more energy efficient speakers, all while remarkably improving sound quality. With a simple drop-in replacement of the speaker’s membrane, GrapheneQ can 1) extend the battery life of a portable audio device by up to 70% b) generate up to 4x the volume and c) significantly reduce the overall size of the speaker, allowing for bigger batteries/thinner devices. ORA's technology is disrupting a technology that has seen little innovation since its invention in 1921: the loudspeaker!

InVivo AI, founded in 2017 and based in Montreal, Canada, specializes in utilizing artificial intelligence to enhance pharmaceutical research and development, particularly in the area of preclinical toxicology. The company aims to streamline the drug discovery process by implementing advanced AI methods for molecular representation and de novo design, which allows for the creation of novel chemical compounds that can address complex biological challenges. Through its innovative platform, InVivo AI is positioned to significantly improve the efficiency and effectiveness of drug design, paving the way for breakthroughs in pharmaceutical science.

Ourly is a digital allowance platform for banks that provides tools to remove the friction that parents and kids struggle with regarding money matters. Their best-in-breed SaaS platform empowers financial institutions to “turn on” financial literacy as a youth banking solution – standalone or integrated.

Nomic is a bioengineering company focused on making the human proteome as accessible as the human genome. The company is developing the nELISA, a next-generation platform for measuring proteins at high throughput and scale. Nomic provides scientists with protein profiling solutions, allowing them to determine the scope and scale of their experiments. Their platform features cost-effective measurement of protein data and integrates smoothly with industry-standard cytometers for high-throughput analysis. Additionally, Nomic's technology enables the development of custom protein panels, leveraging nanotechnology to use DNA as a versatile linker to address issues of cross-reactivity in protein measurement.

StreamingFast, founded by a team of experienced tech entrepreneurs, specializes in developing highly scalable open-source software designed for processing and indexing blockchain data. Based in Montreal, Canada, the company leverages its expertise in large-scale data science to create innovative solutions. Its flagship innovation, the Firehose, employs a file-based and streaming-first approach to handle blockchain data efficiently, facilitating high-performance indexing on high-throughput chains.

Nimble Science Ltd. is a digital health company focused on transforming gastrointestinal health through its innovative SIMBA capsule technology. This platform enables the passive sampling of small bowel luminal fluid, allowing for the collection of precision datasets related to the gastrointestinal tract. By utilizing multi-omic mapping, Nimble Science provides healthcare providers with direct insights into specific regions of the GI system, facilitating improved diagnosis and treatment strategies. The company's approach represents a significant advancement in understanding and managing gastrointestinal health.

HumanFirst is the playground for prompt and data work. Experiment with raw data, surface business-specific insights, and build reliable AI workflows with speed, accuracy, and trust. With a low-code platform and enterprise-grade security posture, HumanFirst empowers enterprises to transform every team into AI experts.

Sollum Technologies, based in Montréal, Canada, specializes in advanced LED lighting solutions for greenhouse producers that mimic the full spectrum of natural sunlight. The company focuses on designing, developing, and manufacturing lighting systems that adapt to the specific growth cycles of various plants, regardless of their native climates. By collaborating closely with clients, Sollum creates customized lighting recipes that enhance energy efficiency, boost productivity, and improve the quality of produce. Their innovative approach not only maximizes plant yield but also emphasizes environmental sustainability, making Sollum's offerings valuable for greenhouse and breeding farm operations seeking to optimize their growing conditions.

Seqera develops workflow orchestration software aimed at simplifying complex data analysis for life sciences research. The company's platform consolidates fragmented data and diverse computing resources, enabling scientists to create and deploy scalable data analysis pipelines in multi-cloud environments with ease. By empowering researchers with modern software tools, Seqera enhances productivity and accelerates scientific discovery across fields such as genomics and global health. Trusted by over 150 leading life science organizations, Seqera's solutions facilitate faster and more confident scientific inquiry, supporting innovation and collaboration in an increasingly data-driven world.